Phase II Study of Docetaxel and Cisplatin as First-line Chemotherapy in Patients with Recurrent or Metastatic Gastric Cance

समान संसाधन

• Combination chemotherapy with epirubicin, docetaxel and cisplatin (EDP) in metastatic or recurrent, unresectable gastric cancer
  द्वारा: Lee, S-H, और अन्य
  प्रकाशित: (2004)
• A Multicenter Randomized Phase II Study of Docetaxel vs. Docetaxel Plus Cisplatin vs. Docetaxel Plus S-1 as Second-Line Chemotherapy in Metastatic Gastric Cancer Patients Who Had Progressed after Cisplatin Plus Either S-1 or Capecitabine
  द्वारा: Lee, Keun-Wook, और अन्य
  प्रकाशित: (2017)
• Phase II study of palliative S-1 in combination with cisplatin as second-line chemotherapy for gemcitabine-refractory pancreatic cancer patients
  द्वारा: KIM, HYUN JUNG, और अन्य
  प्रकाशित: (2012)
• Evaluating the recent developments in palliative chemotherapy for metastatic colorectal cancer
  द्वारा: Baek, Sun Kyung, और अन्य
  प्रकाशित: (2019)
• Efficacy and Safety of Oxaliplatin, 5-Fluorouracil, and Folinic Acid Combination Chemotherapy as First-Line Treatment in Metastatic or Recurrent Gastric Cancer
  द्वारा: Kim, Han Jo, और अन्य
  प्रकाशित: (2011)